PalmettoGBA Announces New Web Tool |
|
| PalmettoGBA has announced a new Web tool, the Denial Finder. This new tool is a meant to assist providers by displaying resources for the most common questions and claim problems. The information is categorized by topic. It integrates all of the resources we have available for the top problem and question categories. Searching for resources will be much easier with this new format. The Denial Finder is located on the PalmettoGBA Ohio home page under “Cool Tools and Top Links. Go to
http://www.PalmettoGBA.com/boh
for more information.
FDA Approves Second-Generation Smallpox Vaccine The U.S. Food and Drug Administration has licensed a new vaccine to protect against smallpox, a highly contagious disease with the potential to be used as a deadly bioterror weapon. The vaccine, ACAM2000, is intended for the inoculation of people at high risk of exposure to smallpox and could be used to protect individuals and populations during a bioterrorist attack. It will be included in the Center for Disease Control and Prevention's (CDC) Strategic National Stockpile of medical supplies. ACAM2000 is made using a pox virus called vaccinia, which is related to but different from the virus that causes smallpox. The vaccine contains live vaccinia virus and works by causing a mild infection that stimulates an immune response that effectively protects against smallpox without actually causing the disease. The vaccine is derived from the only other smallpox vaccine licensed by FDA, Dryvax, approved in 1931 and now in limited supply because it is no longer manufactured. |
|
|
|
|